Showing results (101-110 of 192) with videos related to
Sort By:
Pageof 20
Behavioral Neuroscience|February 1, 1995
NMDA antagonist effects on the development of L-dopa behavioral sensitization in ratsM Pinheiro-Carrera, C Tomaz, J P Huston, et al.Psychopharmacology|May 1, 2007
Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving ratsM Pum, R J Carey, J P Huston, et al.Biochemical Pharmacology|January 6, 1995
Uptake and cytotoxicity of 9-methoxy-N2-methylellipticinium acetate in human brain and non-brain tumor cell linesS Kenney, D T Vistica, H Linden, et al.The American Journal of Physiology|May 1, 1975
Polyuria and imparied ADH release following medial preoptic lesioning in the ratM van Gemert, M Miller, R J Carey, et al.Human Gene Therapy|June 13, 1998
Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectorsS Kenney, J Q Ge, E M Westphal, et al.Journal of Virology|September 1, 1989
The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivatorsS Kenney, E Holley-Guthrie, E C Mar, et al.Carcinogenesis|November 1, 1987
Inhibition of intercellular communication by nickel(II): antagonistic effect of magnesiumH Miki, K S Kasprzak, S Kenney, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Role of membrane potential in the accumulation of quaternized ellipticines by human tumor cell linesD T Vistica, S Kenney, M Hursey, et al.Biochemical Genetics|April 1, 1981
Actin acetylation in Drosophila tissue culture cellsE M Berger, G Cox, L Weber, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1993
Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infectionN D Sista, J S Pagano, W Liao, et al.Pageof 20